CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for tough skin cancers
Disease control OngoingThis study tests whether combining radiation therapy with the immunotherapy drug cemiplimab can help people with a type of advanced skin cancer called cutaneous squamous cell carcinoma that cannot be removed by surgery. About 34 participants will receive this treatment to see if …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:52 UTC
-
New hope for transplant patients with skin cancer: RP1 trial launches
Disease control OngoingThis study tests a drug called RP1, which is injected directly into skin cancer tumors. It is for people who have had an organ or stem cell transplant and now have advanced skin cancer. The goal is to see if RP1 can shrink tumors safely without harming the transplanted organ. Abo…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Can a pre-surgery drug boost skin cancer outcomes? new trial investigates.
Disease control OngoingThis early-phase study tests whether giving the drug cemiplimab before tumor removal surgery is safe for people with Merkel cell carcinoma or cutaneous squamous cell carcinoma. About 36 adults with stage I-II or recurrent disease will receive the drug and then have surgery. Resea…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Exercise before immunotherapy: a new weapon against skin cancer?
Disease control OngoingThis small pilot study looks at whether doing 20-30 minutes of moderate exercise right before immunotherapy can help the treatment work better for people with certain skin cancers (melanoma, squamous cell carcinoma, and Merkel cell carcinoma). The study includes 12 adults schedul…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Flash of hope: new Ultra-Fast radiation may tame skin cancer with fewer side effects
Disease control OngoingThis study tests a new type of radiation called FLASH, which delivers treatment in a fraction of a second, against standard radiotherapy for people with localized skin cancers (basal cell or squamous cell carcinoma). The goal is to see if FLASH can control the tumor just as well …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Exercise before immunotherapy: a new weapon against skin cancer?
Disease control OngoingThis early-phase study tests whether 30 minutes of moderate exercise (like cycling or walking) right before each immunotherapy treatment can help the body fight skin cancers such as melanoma. The study involves 22 adults who are about to start standard immunotherapy. Researchers …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug shows promise in keeping High-Risk skin cancer at bay
Disease control OngoingThis study tests whether an immunotherapy drug called cemiplimab can help prevent high-risk skin cancer (cutaneous squamous cell carcinoma) from returning after surgery and radiation. About 415 participants will receive either cemiplimab or a placebo. The main goal is to see if t…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New pill shows promise against tough skin cancer
Disease control OngoingThis study tests an experimental drug called INCB099280 in 63 adults with advanced squamous cell skin cancer that cannot be removed by surgery or radiation. The main goals are to see if the drug is safe and whether it can shrink tumors. Participants take the drug by mouth and are…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New antibody drug shows promise in early cancer trial
Disease control OngoingThis early-stage study tests a new drug called IMT-009 in people with advanced solid tumors or lymphomas that have not responded to standard treatments. The main goals are to find a safe dose and learn about side effects. About 67 participants will receive the drug intravenously,…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
New combo therapy aims to turn tumors against themselves in advanced cancer patients
Disease control OngoingThis early-phase study tests whether a mix of drugs and targeted radiation can help the immune system recognize and attack hard-to-treat solid tumors. About 14 adults with advanced melanoma, breast cancer, or other solid cancers that cannot be surgically removed will receive inje…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 11, 2026 20:38 UTC